04/10/2022 - 17:08

Published research proves a boost to Radiopharm antibody

04/10/2022 - 17:08


Save articles for future reference.

ASX-listed Radiopharm Theranostics says a new report published by prestigious science journal Nature on the role of cancer catalyst LRRC15 in the growth of tumours could demonstrate the effectiveness of the company’s DUNP19 antibody. LRRC15 is a substance produced by aggressive cancer cells and cells in the surrounding micro-environment, but not healthy normal tissue.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options